These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 29067463)
1. IGFBP-rP1 acts as a potential tumor suppressor via the suppression of ERK signaling pathway in endometrial cancer cells. Ma Y; Jiang J; Zhang Y; Ding Y; Xu T; Lu B Mol Med Rep; 2017 Aug; 16(2):1445-1450. PubMed ID: 29067463 [TBL] [Abstract][Full Text] [Related]
2. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells. Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074 [TBL] [Abstract][Full Text] [Related]
3. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190 [TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Ma Y; Lu B; Ruan W; Wang H; Lin J; Hu H; Deng H; Huang Q; Lai M Exp Mol Pathol; 2008 Oct; 85(2):141-5. PubMed ID: 18701096 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184 [TBL] [Abstract][Full Text] [Related]
6. Sirtuin 2 in Endometrial Cancer: A Potential Regulator for Cell Proliferation, Apoptosis and RAS/ERK Pathway. Guo Y; Zhao N; Zhou J; Dong J; Wang X Technol Cancer Res Treat; 2020; 19():1533033820980781. PubMed ID: 33327875 [TBL] [Abstract][Full Text] [Related]
7. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice]. Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. Li LH; Zhang PR; Cai PY; Li ZC Biomed Pharmacother; 2016 Aug; 82():161-6. PubMed ID: 27470351 [TBL] [Abstract][Full Text] [Related]
9. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406 [TBL] [Abstract][Full Text] [Related]
11. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression. Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. Gysin S; Lee SH; Dean NM; McMahon M Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308 [TBL] [Abstract][Full Text] [Related]
13. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors. López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160 [TBL] [Abstract][Full Text] [Related]
14. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Cho JH; Lee JG; Yang YI; Kim JH; Ahn JH; Baek NI; Lee KT; Choi JH Food Chem Toxicol; 2011 Aug; 49(8):1737-44. PubMed ID: 21554918 [TBL] [Abstract][Full Text] [Related]
15. IGFBP‑rP1‑silencing promotes hypoxia‑induced angiogenic potential of choroidal endothelial cells via the RAF/MEK/ERK signaling pathway. Zhu S; Wang H; Zhang Z; Ma M; Zheng Z; Xu X; Sun T Mol Med Rep; 2020 Dec; 22(6):4837-4847. PubMed ID: 33173998 [TBL] [Abstract][Full Text] [Related]
16. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway. Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway. Guo Y; Zhang Y; Zhang Q; Guo X; Zhang H; Zheng G; Liu L Hepatol Int; 2015 Jan; 9(1):130-41. PubMed ID: 25788387 [TBL] [Abstract][Full Text] [Related]
18. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways. Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696 [TBL] [Abstract][Full Text] [Related]
20. An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence. Rovillain E; Mansfield L; Lord CJ; Ashworth A; Jat PS BMC Genomics; 2011 Jul; 12():355. PubMed ID: 21740549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]